Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

GNMSF

GENMAB A/S

CIK 0001434265 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$337.00
↑ 2.00 (0.60%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 2/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals, Technicals; Excluded: Ownership, Options (no data)

Key stats

Market Cap
Not covered
P/E Ratio
Not covered
EPS
15.50
Dividend Yield
Not covered
52W Position
87%
Beta
0.13

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
Not covered
P/S
Not covered
EV/Revenue
Not covered
ROE
16.5%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 87%
$232.34$352.00

Latest Financials

2025-12-31 FY
Revenue
$3.72B
Net Income
$963.00M
Total Assets
$12.87B
Free Cash Flow
$1.15B

Recent news